MOUNTAIN VIEW, Calif., Dec. 5, 2024 /PRNewswire/ -- AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced that the company has been named 2024 Inc ...

AliveCor has spent years battling with Apple over the market for consumer heart monitoring technology. Now it’s hoping to make its imprint on professional health care with its new device, which ...

The MarketWatch News Department was not involved in the creation of this content. MOUNTAIN VIEW, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- AliveCor, the global leader in AI-powered cardiology, today ...

MOUNTAIN VIEW, Calif., April 15, 2026 (GLOBE NEWSWIRE)-- AliveCor, the global leader in AI-powered cardiology, today announced it has received CE Mark (Conformité Européenne) for the Kardia™ 12L ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Gadgets are fun to use, but they rarely get FDA clearance to be marketed ...

AliveCor has unveiled the KardiaMobile 6L Max portable electrocardiogram (ECG/EKG) for smartphones, designed for the early detection of heart problems. The Max captures more useful data than ...

AliveCor, developer of the iPhone ECG, announced this week that it has raised $3 million in its first round of funding. The investment was funded by Burrill & Company, Qualcomm Ventures and the ...

Thin is in for AliveCor: The personal electrocardiogram maker scored FDA clearance for its slimmest heart monitor yet, which is the size and shape of a credit card and aptly named the KardiaMobile ...

The KardiaMobile 6L requires contacts on both fingers, plus a knee or ankle. The $150 iOS and Android-compatible KardiaMobile 6L is the only consumer-sold six-lead ECG (other portable devices, like ...

Hot on the heels of a major win for Apple in its patent dispute with fellow wearable device maker AliveCor, the tech giant has hit a roadblock. The U.S. International Trade Commission (ITC) ruled last ...